INDICATIONS FOR SWITCHING BIOLOGICAL THERAPY IN PATIENTS WITHPSORIATIC ARTHRITIS

Authors

  • Мартин Николов Клиника по ревматология
  • Nikolay Nikolov
  • Svilen Angelov
  • Vasilena Dimitrova
  • Petya Marinova
  • Aleksandra Tsenova

Keywords:

psoriatic arthritis, biological therapy, switching, joint pain syndrome, adverse drug reactions, therapeutic failure

Abstract

The presentation outlines the most common reasons for switching biological therapy in patients with psoriatic arthritis. It includes an analysis of five patients aged between 30 and 74 years with psoriatic arthritis who required a change in their biological therapy. Various indications for discontinuation of a given biological agent are discussed, including the development of antibodies against it, insufficient effect on disease activity, occurrence of adverse drug reactions, or contraindications.

Published

2025-07-15

Issue

Vol. 8 No. 2 (2025)

Section

Articles